Global Osmotic Laxative Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Osmotic Laxative Market Research Report 2024
Osmotic laxatives are hypertonic agents that holds more water colon and generate an osmotic effect that stimulates a bowel movement and results in softer stools. Osmotic laxatives are considered as the drug of choice for treatment of constipation. Lactulose, Polyethene glycol (PEG) and milk of magnesia are some commonly used osmotic laxatives. In February 2020, LACTITOL manufactured by Braintree laboratories was approved by USFDA as an osmotic laxative for the treatment of chronic idiopathic constipation (CIC).
According to MRAResearch’s new survey, global Osmotic Laxative market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Osmotic Laxative market research.
Key companies engaged in the Osmotic Laxative industry include Abbott Laboratories, Bayer AG, Procter & Gamble Company, GlaxoSmithKline Consumer Healthcare, Purdue Pharma, Sucampo Pharmaceuticals Inc., Salix Pharmaceuticals, Pharmos Corporation and Lexicon Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Osmotic Laxative were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Osmotic Laxative market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Osmotic Laxative market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abbott Laboratories
Bayer AG
Procter & Gamble Company
GlaxoSmithKline Consumer Healthcare
Purdue Pharma
Sucampo Pharmaceuticals Inc.
Salix Pharmaceuticals
Pharmos Corporation
Lexicon Pharmaceuticals
Tioga Pharmaceuticals
Alimentary Health Limited
Boehringer Ingelheim Pharmaceuticals Inc.
Sucampo Pharmaceuticals, Inc.
Segment by Type
Lactulose
Sorbitol
Magnesium Citrate
Milk of Magnesia
Polyethylene Glycol
Drug Store
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Osmotic Laxative report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Osmotic Laxative market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Osmotic Laxative market research.
Key companies engaged in the Osmotic Laxative industry include Abbott Laboratories, Bayer AG, Procter & Gamble Company, GlaxoSmithKline Consumer Healthcare, Purdue Pharma, Sucampo Pharmaceuticals Inc., Salix Pharmaceuticals, Pharmos Corporation and Lexicon Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Osmotic Laxative were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Osmotic Laxative market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Osmotic Laxative market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
Bayer AG
Procter & Gamble Company
GlaxoSmithKline Consumer Healthcare
Purdue Pharma
Sucampo Pharmaceuticals Inc.
Salix Pharmaceuticals
Pharmos Corporation
Lexicon Pharmaceuticals
Tioga Pharmaceuticals
Alimentary Health Limited
Boehringer Ingelheim Pharmaceuticals Inc.
Sucampo Pharmaceuticals, Inc.
Segment by Type
Lactulose
Sorbitol
Magnesium Citrate
Milk of Magnesia
Polyethylene Glycol
Segment by Application
Drug Store
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Osmotic Laxative report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source